ID: ALA4548417

Max Phase: Preclinical

Molecular Formula: C47H57N11O10

Molecular Weight: 936.04

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CC(=O)NCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cn3)nc2n(C2CCCC2)c1=O

Standard InChI:  InChI=1S/C47H57N11O10/c1-29-34-27-51-47(54-42(34)57(31-6-3-4-7-31)45(64)40(29)30(2)59)52-37-12-10-32(26-50-37)56-18-16-55(17-19-56)28-39(61)49-15-21-67-23-25-68-24-22-66-20-14-48-35-9-5-8-33-41(35)46(65)58(44(33)63)36-11-13-38(60)53-43(36)62/h5,8-10,12,26-27,31,36,48H,3-4,6-7,11,13-25,28H2,1-2H3,(H,49,61)(H,53,60,62)(H,50,51,52,54)

Standard InChI Key:  UTSBHEVQCONLCR-UHFFFAOYSA-N

Associated Targets(Human)

Protein cereblon/Cyclin-dependent kinase 6 113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein cereblon/Cyclin-dependent kinase 4 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 4/cyclin D1 2340 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CDK6/cyclin D3 897 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/Cyclin-dependent kinase 4 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/CDK6 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cereblon/Ikaros 139 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MM1.S 1111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cereblon/Aiolos 164 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 936.04Molecular Weight (Monoisotopic): 935.4290AlogP: 2.36#Rotatable Bonds: 21
Polar Surface Area: 248.62Molecular Species: NEUTRALHBA: 18HBD: 4
#RO5 Violations: 2HBA (Lipinski): 21HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.15CX Basic pKa: 6.10CX LogP: 1.87CX LogD: 1.85
Aromatic Rings: 4Heavy Atoms: 68QED Weighted: 0.05Np Likeness Score: -1.10

References

1. Su S, Yang Z, Gao H, Yang H, Zhu S, An Z, Wang J, Li Q, Chandarlapaty S, Deng H, Wu W, Rao Y..  (2019)  Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders.,  62  (16): [PMID:31330105] [10.1021/acs.jmedchem.9b00871]
2. Anderson NA, Cryan J, Ahmed A, Dai H, McGonagle GA, Rozier C, Benowitz AB..  (2020)  Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs.,  30  (9): [PMID:32184044] [10.1016/j.bmcl.2020.127106]
3. Bricelj A, Dora Ng YL, Ferber D, Kuchta R, Müller S, Monschke M, Wagner KG, Krönke J, Sosič I, Gütschow M, Steinebach C..  (2021)  Influence of Linker Attachment Points on the Stability and Neosubstrate Degradation of Cereblon Ligands.,  12  (11.0): [PMID:34795861] [10.1021/acsmedchemlett.1c00368]

Source